<DOC>
	<DOCNO>NCT00109122</DOCNO>
	<brief_summary>The purpose study determine immunity ( body 's protection ) shingle receive two dos investigational vaccine placebo ( look alike vaccine active ingredient ) .</brief_summary>
	<brief_title>Safety , Tolerability , Body 's Ability Develop Resistance Investigational Vaccine Shingles ( V211-007 )</brief_title>
	<detailed_description>The duration treatment 12 week .</detailed_description>
	<mesh_term>Herpes Zoster</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Individuals least 60 year age history varicella ( shingle ) Females must postmenopausal . Subjects previously participate main study protocol . Subject shingle since 6 month followup visit main phase study .</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>